Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,266,598
+$276,006 QoQ
Shares Held
1,056
-1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2,916
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Linscomb Wealth, Inc. holds $62,600,297 across 7 Drug Manufacturers - General names. LLY ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
70,722 | $17,796,484 | |
| 2 | JNJ |
Johnson & Johnson
|
59,468 | $15,103,087 | |
| 3 | MRK |
Merck & Co., Inc.
|
92,395 | $11,872,757 | |
| 4 | AMGN |
Amgen Inc
|
29,620 | $10,725,994 | |
| 5 | PFE |
Pfizer Inc
|
209,174 | $5,036,909 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
1,056 | $1,266,598 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,320 | $798,468 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,266,598 | 1,056 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $990,592 | 1,077 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,166,007 | 2,946 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,493,484 | 3,268 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,548,283 | 3,269 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,659,430 | 3,220 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,643,328 | 3,424 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,897,023 | 3,270 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,963,308 | 3,273 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,636,506 | 3,389 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,965,606 | 3,372 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,939,576 | 3,611 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,711,308 | 3,649 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,255,886 | 3,657 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,220,442 | 3,336 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $909,906 | 2,814 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $912,383 | 2,814 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $863,691 | 3,016 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $679,224 | 2,459 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $553,595 | 2,396 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $556,815 | 2,426 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $447,807 | 2,397 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $406,904 | 2,410 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $411,051 | 2,777 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $432,121 | 2,632 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $375,653 | 2,708 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||